Prime Medicine, Inc. (PRME)
(Delayed Data from NSDQ)
$3.51 USD
+0.10 (2.93%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $3.52 +0.01 (0.28%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/01/2024
Time: -- |
9/2024 | $-0.44 | 0.00% |
Earnings Summary
For their last quarter, Prime Medicine, Inc. (PRME) reported earnings of -$0.46 per share, missing the Zacks Consensus Estimate of -$0.40 per share. This reflects a negative earnings surprise of 15.00%. Look out for PRME's next earnings release expected on November 01, 2024. For the next earning release, we expect the company to report earnings of -$0.44 per share, reflecting a year-over-year increase of 20%.
Earnings History
Price & Consensus
Zacks News for PRME
Prime Medicine (PRME) Stock: Buy or Sell Before Q2 Earnings?
PRME: What are Zacks experts saying now?
Zacks Private Portfolio Services